With more than 15 years of commercial experience in the global Life Sciences industry, Kimberley brings deep expertise in biosafety testing for Cell and Gene Therapy (CGT), Biologics, and Vaccine manufacturing. As the Business Development Manager at PathoQuest SAS, she leads partnerships across the UK, Netherlands, and Asia-Pacific, driving the adoption of GMP-compliant Next Generation Sequencing (NGS) to support the development of advanced therapeutic modalities. Kimberley holds a Bachelor of Science from Saint Mary’s College, and has a strong track record of connecting cutting-edge technologies with the evolving needs of biopharmaceutical manufacturers.